Natural Alternatives International (NAII) 10-Q 14 May 24 2024 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Mar. 31, 2024	May 14, 2024
Document Information [Line Items]
Entity Central Index Key	0000787253
Entity Registrant Name	NATURAL ALTERNATIVES INTERNATIONAL INC
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2024
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Entity File Number	000-15701
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	84-1007839
Entity Address, Address Line One	1535 Faraday Ave
Entity Address, City or Town	Carlsbad
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	92008
City Area Code	760
Local Phone Number	736-7700
Title of 12(b) Security	Common Stock, $0.01 par value per share
Trading Symbol	NAII
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Emerging Growth Company	false
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		3,280,037

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Jun. 30, 2023
Current assets:
Cash and cash equivalents	$ 12,407	$ 13,604
Accounts receivable – less allowance for doubtful accounts of $0 at March 31, 2024 and $23 at June 30, 2023	11,221	7,022
Inventories, net	21,071	29,694
Income tax receivable	1,662	305
Derivative assets, current asset	335	390
Prepaids and other current assets	7,665	5,995
Total current assets	54,361	57,010
Property and equipment, net	52,384	53,841
Operating lease right-of-use assets	44,032	20,369
Deferred tax asset – noncurrent	291	355
Other noncurrent assets, net	2,143	2,577
Total assets	153,211	134,152
Current liabilities:
Accounts payable	6,970	7,778
Accrued liabilities	2,425	2,409
Accrued compensation and employee benefits	2,092	2,246
Customer deposits	387	317
Short-term liability – operating leases	1,134	2,448
Forward contracts	345	0
Income taxes payable	0	374
Mortgage note payable, current portion	294	312
Total current liabilities	13,647	15,884
Long-term liability – operating leases	45,423	18,965
Long-term pension liability	295	339
Mortgage note payable, net of current portion	9,007	9,205
Income taxes payable, noncurrent	740	987
Total liabilities	69,112	45,380
Commitments and contingencies (Notes E, F, and L)
Stockholders’ equity:
Preferred stock; $.01 par value; 500,000 shares authorized; none issued or outstanding	0	0
Common stock; $.01 par value; 20,000,000 shares authorized at March 31, 2024 and June 30, 2023, issued and outstanding (net of treasury shares) 6,200,869 at March 31, 2024 and 6,073,813 at June 30, 2023	93	91
Additional paid-in capital	32,356	31,436
Retained earnings	74,840	80,183
Treasury stock, at cost, 3,280,037 shares at March 31, 2024 and 3,240,593 at June 30, 2023	(23,072)	(22,855)
Accumulated other comprehensive income	(118)	(83)
Total stockholders’ equity	84,099	88,772
Total liabilities and stockholders’ equity	$ 153,211	$ 134,152

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) $ in Thousands	Mar. 31, 2024	Jun. 30, 2023
Accounts receivable, allowance for doubtful accounts	$ 0	$ 23
Preferred stock par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	500,000	500,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	20,000,000	20,000,000
Common stock, shares issued (in shares)	6,200,869	6,073,813
Common stock, shares outstanding (in shares)	6,200,869	6,073,813
Treasury stock, shares (in shares)	3,280,037	3,240,593

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income and Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Net sales	$ 25,136	$ 32,699	$ 84,307	$ 118,121
Cost of goods sold	23,214	31,323	78,861	105,160
Gross profit	1,922	1,376	5,446	12,961
Selling, general and administrative	3,874	3,864	11,455	11,422
(Loss) income from operations	(1,952)	(2,488)	(6,009)	1,539
Other (expense) income:
Interest income	79	12	100	25
Interest expense	(74)	(116)	(237)	(246)
Foreign exchange loss	(23)	(194)	(540)	(484)
Other, net	2	(2)	3	(18)
Total other expense	(16)	(300)	(674)	(723)
(Loss) income before income taxes	(1,968)	(2,788)	(6,683)	816
(Benefit) provision for income taxes	(390)	(407)	(1,340)	331
Net (loss) income	(1,578)	(2,381)	(5,343)	485
Unrealized gain (loss) resulting from change in fair value of derivative instruments, net of tax	119	(357)	(30)	(1,621)
Comprehensive (loss)	$ (1,459)	$ (2,738)	$ (5,373)	$ (1,136)
Net (loss) income per common share:
Basic (in dollars per share)	$ (0.27)	$ (0.41)	$ (0.91)	$ 0.08
Diluted (in dollars per share)	$ (0.27)	$ (0.41)	$ (0.91)	$ 0.08
Weighted average common shares outstanding
Basic (in shares)	5,867,528	5,816,058	5,855,930	5,867,400
Diluted (in shares)	5,867,528	5,816,058	5,855,930	5,885,116

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Stock, Common [Member]	AOCI Attributable to Parent [Member]	Total
Balance (in shares) at Jun. 30, 2022	9,191,406			3,061,795
Balance at Jun. 30, 2022	$ 89	$ 30,423	$ 77,661	$ (21,352)	$ 1,699	$ 88,520
Compensation expense related to stock compensation plans	$ 0	725	0	$ 0	0	725
Issuance of common stock for restricted stock grants (in shares)	118,000			0
Issuance of common stock for restricted stock grants	$ 2	(2)	0	$ 0	0	0
Repurchase of common stock	$ 0	0	0	$ (1,503)	0	$ (1,503)
Treasury Stock Acquired, Shares (in shares)				164,399		164,399
Forfeiture of restricted stock (in shares)	0			5,999
Forfeiture of restricted stock	$ 0	0	0	$ 0	0	$ 0
Unrealized loss resulting from change in fair value of derivative instruments, net of tax	0	0	0	0	(1,621)	(1,621)
Net income (loss)	0	0	485	0	0	485
Repurchase of common stock	$ 0	0	0	$ (1,503)	0	(1,503)
Balance (in shares) at Mar. 31, 2023	9,309,406			3,232,193
Balance at Mar. 31, 2023	$ 91	31,146	78,146	$ (22,855)	78	86,606
Balance (in shares) at Dec. 31, 2022	9,191,406			3,177,160
Balance at Dec. 31, 2022	$ 89	30,890	80,527	$ (22,411)	435	89,530
Compensation expense related to stock compensation plans	$ 0	258	0	$ 0	0	258
Issuance of common stock for restricted stock grants (in shares)	118,000			0
Issuance of common stock for restricted stock grants	$ 2	(2)	0	$ 0	0	0
Repurchase of common stock	0	0	0	$ (444)	0	$ (444)
Treasury Stock Acquired, Shares (in shares)				49,034		49,034
Unrealized loss resulting from change in fair value of derivative instruments, net of tax	0	0	0	$ 0	(357)	$ (357)
Net income (loss)	0	0	(2,381)	0	0	(2,381)
Repurchase of common stock	$ 0	0	0	$ (444)	0	(444)
Balance (in shares) at Mar. 31, 2023	9,309,406			3,232,193
Balance at Mar. 31, 2023	$ 91	31,146	78,146	$ (22,855)	78	$ 86,606
Balance (in shares) at Jun. 30, 2023	9,314,406			3,240,593		6,073,813
Balance at Jun. 30, 2023	$ 91	31,436	80,183	$ (22,855)	(83)	$ 88,772
Compensation expense related to stock compensation plans	$ 0	922	0	$ 0	0	922
Issuance of common stock for restricted stock grants (in shares)	166,500			0
Issuance of common stock for restricted stock grants	$ 2	(2)	0	$ 0	0	0
Change in minimum pension liability, net of tax	0	0	0	0	(5)	(5)
Repurchase of common stock	$ 0	0	0	$ (217)	0	(217)
Treasury Stock Acquired, Shares (in shares)				36,444
Forfeiture of restricted stock (in shares)	0			3,000
Forfeiture of restricted stock	$ 0	0	0	$ 0	0	0
Unrealized loss resulting from change in fair value of derivative instruments, net of tax	0	0	0	0	(30)	(30)
Net income (loss)	0	0	(5,343)	0	0	(5,343)
Repurchase of common stock	$ 0	0	0	$ (217)	0	$ (217)
Balance (in shares) at Mar. 31, 2024	9,480,906			3,280,037		6,200,869
Balance at Mar. 31, 2024	$ 93	32,356	74,840	$ (23,072)	(118)	$ 84,099
Balance (in shares) at Dec. 31, 2023	9,329,406			3,240,593
Balance at Dec. 31, 2023	$ 91	32,043	76,418	$ (22,855)	(242)	85,455
Compensation expense related to stock compensation plans	$ 0	315	0	$ 0	0	315
Issuance of common stock for restricted stock grants (in shares)	151,500			0
Issuance of common stock for restricted stock grants	$ 2	(2)	0	$ 0	0	0
Change in minimum pension liability, net of tax	0	0	0	0	5	5
Repurchase of common stock	$ 0	0	0	$ (217)	0	$ (217)
Treasury Stock Acquired, Shares (in shares)				36,444		36,444
Forfeiture of restricted stock (in shares)	0			3,000
Forfeiture of restricted stock	$ 0	0	0	$ 0	0	$ 0
Unrealized loss resulting from change in fair value of derivative instruments, net of tax	0	0	0	0	119	119
Net income (loss)	0	0	(1,578)	0	0	(1,578)
Repurchase of common stock	$ 0	0	0	$ (217)	0	$ (217)
Balance (in shares) at Mar. 31, 2024	9,480,906			3,280,037		6,200,869
Balance at Mar. 31, 2024	$ 93	$ 32,356	$ 74,840	$ (23,072)	$ (118)	$ 84,099

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2023
Cash flows from operating activities
Net (loss) income	$ (1,578)	$ (2,381)	$ (5,343)	$ (5,343)	$ 485	$ 485
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:
Recovery of uncollectible accounts receivable			0		(18)
Depreciation and amortization			3,439		3,050
Non-cash compensation			922		725
Non-cash lease expense			4,007		2,937
Pension expense, net of contributions			(44)		75
Gain on disposal of assets			0		(43)
Changes in operating assets and liabilities:
Accounts receivable			(4,199)		9,829
Inventories, net			8,623		(6,834)
Prepaids and other assets			(1,561)		(868)
Accounts payable and accrued liabilities			(722)		(6,178)
Forward contracts			755		517
Accrued compensation and employee benefits			(154)		(614)
Operating lease liabilities			(2,525)		(2,455)
Income taxes			(1,978)		(1,078)
Net cash provided by (used in) operating activities			1,220		(470)
Cash flows from investing activities
Proceeds from sale of property and equipment			0		48
Purchases of property and equipment			(1,983)		(13,239)
Net cash used in investing activities			(1,983)		(13,191)
Cash flows from financing activities
Borrowings on line of credit			0		9,100
Payments on long-term debt			(217)		(209)
Repurchase of common stock			(217)		(1,503)
Net cash (used in) provided by financing activities			(434)		7,388
Net decrease in cash and cash equivalents			(1,197)		(6,273)
Cash and cash equivalents at beginning of period			13,604		21,833
Cash and cash equivalents at end of period	$ 12,407	$ 15,560	12,407	$ 12,407	15,560	$ 15,560
Supplemental disclosures of cash flow information
Interest			184		507
Income taxes			$ 283		$ 1,321

Note A - Basis of Presentation

Note A - Basis of Presentation and Summary of Significant Accounting Policies	9 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]	A. Basis of Presentation and Summary of Significant Accounting Policies The accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10 three nine March 31, 2024 not You should read the financial statements and these notes, which notes are an integral part of the financial statements, together with our audited financial statements included in our Annual Report on Form 10 June 30, 2023 “2023 2023 Recently Adopted Accounting Pronouncements We did not three March 31, 2024. Recently Issued Accounting and Regulatory Pronouncements In October 2023, 2023 06, 2023 06 X not not June 30, 2027. not In November 2023, 2023 07, 280 2023 07 December 15, 2023, 2025. not In December 2023, 2023 09, 740 2023 09 December 15, 2024, first 2026. not In March 2024, No. 33 11275, July 1, 2027. April 2024, may may Net (Loss) Income per Common Share We compute net (loss) income per common share using the weighted average number of common shares outstanding during the period, and diluted net income per common share using the additional dilutive effect of all dilutive securities. The dilutive impact of unvested restricted shares account for the additional weighted average shares of common stock outstanding for our diluted net income per common share computation. We calculated basic and diluted net (loss) income per common share as follows (in thousands, except per share data): Three Months Ended Nine Months Ended March 31, March 31, 2024 2023 2024 2023 Numerator Net (loss) income $ (1,578 ) $ (2,381 ) $ (5,343 ) $ 485 Denominator Basic weighted average common shares outstanding 5,868 5,816 5,856 5,867 Dilutive effect of restricted stock — — — 18 Diluted weighted average common shares outstanding 5,868 5,816 5,856 5,885 Basic net (loss) income per common share $ (0.27 ) $ (0.41 ) $ (0.91 ) $ 0.08 Diluted net (loss) income per common share $ (0.27 ) $ (0.41 ) $ (0.91 ) $ 0.08 We exclude the impact of restricted stock from the calculation of diluted net loss per common share in periods where we have a net loss or when their inclusion would be antidilutive. During the three March 31, 2024, nine March 31, 2024, three March 31, 2023, nine March 31, 2023 Revenue Recognition We record revenue based on a five 1 2 3 4 5 Revenue is measured as the net amount of consideration expected to be received in exchange for fulfilling one 30 Revenue is recognized at the point in time that each of our performance obligations is fulfilled, and control of the ordered products is transferred to the customer. This transfer occurs when the product is shipped, or in some cases, when the product is delivered to the customer. We recognize revenue in certain circumstances before delivery to the customer has occurred (commonly referred to as bill-and-hold transactions). Products sold under bill-and-hold arrangements are recorded as revenue when risk of ownership has been transferred to the customer, but the product has not We provide early payment discounts to certain customers. Based on historical payment trends, we expect that these customers will take advantage of these early payment discounts. The cost of these discounts is reported as a reduction to the transaction price. If the actual discounts differ from those estimated, the difference is also reported as a change in the transaction price. We require prepayment from certain customers. We record any payments received in advance of contract fulfillment as a contract liability and they are classified as customer deposits on the consolidated balance sheet. Contract liabilities and revenue recognized were as follows (in thousands): June 30, 2023 Additions Revenue Recognized Customer Refunds March 31, 2024 Contract Liabilities (Customer Deposits) $ 317 $ 1,406 $ (1,336 ) $ — $ 387 June 30, 2022 Additions Revenue Recognized Customer Refunds March 31, 2023 Contract Liabilities (Customer Deposits) $ 140 $ 326 $ (137 ) $ (3 ) $ 326 Except for product defects, no March 31, 2024 We currently own certain U.S. patents, and each patent’s corresponding foreign patent applications. All of these patents and patent rights relate to the ingredient known as beta-alanine marketed and sold under our CarnoSyn® and SR CarnoSyn® trade names. We recorded beta-alanine raw material sales and royalty and licensing income as a component of revenue in the amount of $2.7 million during the three March 31, 2024 nine March 31, 2024. three March 31, 2023 nine March 31, 2023. three March 31, 2024 nine March 31, 2024. three March 31, 2023 nine March 31, 2023. Stock-Based Compensation The Board of Directors approved our current omnibus equity incentive plan that became effective January 1, 2021 ( “2020 2020 December 4, 2020. 2020 may We did not three nine March 31, 2024 March 31, 2023 During the three March 31, 2024 nine March 31, 2024, three nine March 31, 2023, three nine March 31, 2024, three nine March 31, 2023, three March 31, 2024 nine March 31, 2024. three March 31, 2023, nine March 31, 2023. Deferred Compensation Plan Effective July 16, 2020, may The Incentive Plan authorizes the Human Resources Committee or the Board of Directors to grant to, and administer, unsecured and deferred cash Awards to Participants and to subject each Award to whatever conditions are determined appropriate by the Human Resources Committee or the Board of Directors. The terms of each Award, including the amount and any conditions that must be met to be entitled to payment of the Award are set forth in an Award Agreement between each Participant and NAI. The Incentive Plan provides the Board of Directors with the discretion to set aside assets to fund the Incentive Plan although that has not During the three nine March 31, 2024, three nine March 31, 2023, three one two three no No deferred cash awards were forfeited during the three nine March 31, 2024 March 31, 2023 Fair Value of Financial Instruments Except for cash and cash equivalents, as of March 31, 2024 June 30, 2023 not 1. 2 third Fair value of derivative instruments classified as Level 2 March 31, 2024 June 30, 2023 Euro Forward Contract– Current Assets $ 335 $ 250 Swiss Franc Forward Contract – Current Assets — 140 Total Derivative Contracts – Current Assets 335 390 Interest Swap – Other noncurrent Assets 221 532 Euro Forward Contract– Other noncurrent Assets — 15 Total Derivative Contracts – Other noncurrent Assets 221 547 Euro Forward Contract– Current Liabilities — — Swiss Franc Forward Contract – Current Liabilities (345 ) — Total Derivative Contracts – Current Liabilities (345 ) — Fair Value Net Asset – all Derivative Contracts $ 211 $ 937 We also classify any outstanding line of credit and term loan balance as a Level 2 March 31, 2024 June 30, 2023 not 3. not 2023 three nine March 31, 2024

Note B - Inventories, Net

Note B - Inventories, Net	9 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Inventory Disclosure [Text Block]	B. Inventories, net Inventories, net consisted of the following (in thousands): March 31, June 30, 2024 2023 Raw materials $ 15,219 $ 20,946 Work in progress 3,261 4,504 Finished goods 3,273 4,928 Reserve (682 ) (684 ) $ 21,071 $ 29,694

Note C - Property and Equipment

Note C - Property and Equipment	9 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	C. Property and Equipment Property and equipment consisted of the following (in thousands): Depreciable Life March 31, June 30, In Years 2024 2023 Land NA $ 8,941 $ 8,940 Building and building improvements 7 – 39 25,251 24,712 Machinery and equipment 3 – 12 42,318 41,460 Office equipment and furniture 3 – 5 6,616 6,522 Vehicles 3 227 227 Leasehold improvements 1 – 15 23,133 22,641 Total property and equipment 106,486 104,502 Less: accumulated depreciation and amortization (54,102 ) (50,661 ) Property and equipment, net $ 52,384 $ 53,841 Depreciation and amortization expense was approximately $1.1 million during the three March 31, 2024 nine March 31, 2024. three March 31, 2023 nine March 31, 2023.

Note D - Other Comprehensive (L

Note D - Other Comprehensive (Loss) Income	9 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Comprehensive Income (Loss) Note [Text Block]	D. Other Comprehensive (Loss) Income Other comprehensive (loss) income (“OCL” and “OCI”) consisted of the following during the three nine March 31, 2024 March 31, 2023 Three Months Ended March 31, 2024 Defined Unrealized (Losses) Unrealized Gains Benefit Gains on (Losses) on Pension Cash Flow Swap Plan Hedges Derivative Total Beginning Balance $ (390 ) $ (104 ) $ 252 $ (242 ) OCI/OCL before reclassifications — 285 (96 ) 189 Amounts reclassified from OCI to Sales — (35 ) — (35 ) Tax effect of OCI activity 5 (52 ) 17 (30 ) Net current period OCI/OCL 5 198 (79 ) 124 Ending Balance $ (385 ) $ 94 $ 173 $ (118 ) Nine Months Ended March 31, 2024 Defined Unrealized Gains Unrealized Gains Benefit (Losses) on (Losses) on Pension Cash Flow Swap Plan Hedges Derivative Total Beginning Balance $ (380 ) $ (110 ) $ 407 $ (83 ) OCI/OCL before reclassifications — 286 (311 ) (25 ) Amounts reclassified from OCI to Sales — 54 — 54 Tax effect of OCI activity (5 ) (136 ) 77 (64 ) Net current period OCI/OCL (5 ) 204 (234 ) (35 ) Ending Balance $ (385 ) $ 94 $ 173 $ (118 ) Three Months Ended March 31, 2023 Defined Unrealized Gains Unrealized Gains Benefit (Losses) on (Losses) on Pension Cash Flow Swap Plan Hedges Derivative Total Beginning Balance $ (444 ) $ 391 $ 488 $ 435 OCI/OCL before reclassifications — 713 (90 ) 623 Amounts reclassified from OCI to Sales — (1,181 ) — (1,181 ) Tax effect of OCI activity — 122 79 201 Net current period OCI/OCL — (346 ) (11 ) (357 ) Ending Balance $ (444 ) $ 45 $ 477 $ 78 Nine Months Ended March 31, 2023 Defined Unrealized Gains Unrealized Gains Benefit (Losses) on (Losses) on Pension Cash Flow Swap Plan Hedges Derivative Total Beginning Balance $ (444 ) $ 1,795 $ 348 $ 1,699 OCI/OCL before reclassifications — 1,328 88 1,416 Amounts reclassified from OCI to Sales — (3,604 ) 41 (3,563 ) Tax effect of OCI activity — 526 — 526 Net current period OCI/OCL — (1,750 ) 129 (1,621 ) Ending Balance $ (444 ) $ 45 $ 477 $ 78

Note E - Leases

Note E - Leases	9 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Lessee, Operating Leases [Text Block]	E. Leases We currently lease our Vista, California and Lugano, Switzerland product manufacturing and support facilities. On July 18, 2023, ten five April 1, 2024. two five not On January 26, 2024, 9 8 April 30, 2024. Our leases are classified as operating leases. Substantially all our operating leases are comprised of payments for the use of manufacturing and office space. We have no March 31, 2024 June 30, 2023 Other information related to leases as of March 31, 2024 March 31, 2023 Supplemental Cash Flow Information Nine Months Ended Nine Months Ended March 31, 2024 March 31, 2023 Cash paid for amounts included in the measurement of operating lease liabilities $ 2,523 $ 2,433 Increase in operating lease liabilities and right-of-use assets due to lease remeasurement $ 25,589 $ —

Note F - Debt

Note F - Debt	9 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Debt Disclosure [Text Block]	F. Debt On May 24, 2021, November 1, 2022, May 24, 2024. August 18, 2021, $10.0 2022 Subsequently we entered into a Second and Third Amendment that changed certain limits on our use of the line of credit. In the second 2024 three not second February 13, 2024, On December 31, 2023, not February 13, 2024, fourth not 1.0 three not September 30, 2024; ( four not 1.0 December 31, 2024 May 23, 2025. may may The Term Note used as part of the purchase consideration of our powder processing and warehouse property in Carlsbad, California referenced above, was for the original principal amount of $10.0 million, and is a seven twenty-five October 1, 2021, August 1, 2028, September 1, 2028. 30 first three Our obligations under the Credit Agreement are secured by our accounts receivable and other rights to payment, general intangibles, inventory, equipment and fixtures. We also have credit approval with Wells Fargo Bank, which allows us to hedge foreign currency exposures up to 30 24 As of March 31, 2024 August 2021 On March 31, 2024, As of March 31, 2024 zero March 31, 2024 .

Note G - Economic Dependency

Note G - Economic Dependency	9 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Concentration Risk Disclosure [Text Block]	G. Economic Dependency We had substantial net sales to certain customers during the periods shown in the following table. The loss of any of these customers, or a significant decline in (i) sales to these customers, (ii) the growth rate of sales to these customers, or (iii) these customers’ ability to make payments when due, each individually could have a material adverse impact on our net sales and net operating results. Net sales to any one 10% Three Months Ended Nine Months Ended March 31, March 31, 2024 2023 2024 2023 Customer 1 $ 11,251 $ 15,962 $ 35,215 $ 46,948 Customer 2 (a) 9,558 13,604 38,823 Customer 3 2,640 (a) (a) (a) $ 13,891 $ 25,520 $ 48,819 $ 85,771 (a) Sales were less than 10% Accounts receivable from these customers totaled $7.6 million at March 31, 2024 June 30, 2023 We buy certain products, including beta-alanine, from a limited number of raw material suppliers who meet our quality standards. The loss of any of these suppliers could have a material adverse impact on our net sales and net income. Raw material purchases from any one 10% Three Months Ended Nine Months Ended March 31, March 31, 2024 2023 2024 2023 Supplier 1 $ 4,149 3,916 $ 10,018 11,394 $ 4,149 $ 3,916 $ 10,018 $ 11,394

Note H - Segment Information

Note H - Segment Information	9 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	H. Segment Information Our business consists of two segments for financial reporting purposes. The two We evaluate performance of these segments based on a number of factors. The primary performance measures for each segment are net sales and income or loss from operations before the allocation of certain corporate level expenses. Operating income or loss for each segment does not not not 2023 Our operating results by business segment were as follows (in thousands): Three Months Ended Nine Months Ended March 31, March 31, 2024 2023 2024 2023 Net Sales Private label contract manufacturing $ 22,479 $ 30,354 $ 77,718 $ 112,969 Patent and trademark licensing 2,657 2,345 6,589 5,152 Total Net Sales $ 25,136 $ 32,699 $ 84,307 $ 118,121 Three Months Ended Nine Months Ended March 31, March 31, 2024 2023 2024 2023 (Loss) Income from Operations Private label contract manufacturing $ (1,007 ) $ (1,243 ) $ (2,367 ) $ 6,264 Patent and trademark licensing 1,201 790 $ 2,592 1,485 Income (Loss) from operations of reportable segments 194 (453 ) $ 225 7,749 Corporate expenses not allocated to segments (2,146 ) (2,035 ) $ (6,234 ) (6,210 ) Total (Loss) Income from Operations $ (1,952 ) $ (2,488 ) $ (6,009 ) $ 1,539 March 31, June 30, 2024 2023 Total Assets Private-label contract manufacturing $ 119,245 $ 102,495 Patent and trademark licensing 33,966 31,657 $ 153,211 $ 134,152 Our private-label contract manufacturing products are sold both in the U.S. and in markets outside the U.S., including Europe, Canada, Australia, New Zealand, Mexico, and Asia. Our primary markets outside the U.S. are Europe and Asia. Our patent and trademark licensing activities are primarily based in the U.S. Net sales by geographic region, based on the customers’ location, were as follows (in thousands): Three Months Ended Nine Months Ended March 31, March 31, 2024 2023 2024 2023 United States $ 15,457 $ 24,254 $ 56,990 $ 82,995 Markets outside of the United States 9,679 8,445 27,317 35,126 Total $ 25,136 $ 32,699 $ 84,307 $ 118,121 Products manufactured by our Swiss subsidiary ("NAIE") accounted for 68% of net sales in markets outside the U.S. for the three March 31, 2024 nine March 31, 2024. three March 31, 2023 nine March 31, 2023. Long-lived assets by geographic region, based on the location of the company or subsidiary at which they were located or made, were as follows (in thousands): March 31, 2024 June 30, 2023 United States $ 78,238 $ 53,536 Europe 18,178 20,674 Total Long-Lived Assets $ 96,416 $ 74,210 Total assets by geographic region, based on the location of the company or subsidiary at which they were located or made, were as follows (in thousands): March 31, 2024 June 30, 2023 United States $ 109,465 $ 89,167 Europe 43,746 44,985 Total Assets $ 153,211 $ 134,152 Capital expenditures by geographic region, based on the location of the company or subsidiary at which they were located or made, were as follows (in thousands): Nine Months Ended March 31, 2024 2023 United States $ 1,801 $ 12,983 Europe 182 256 Total Capital Expenditures $ 1,983 $ 13,239

Note I - Income Taxes

Note I - Income Taxes	9 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Income Tax Disclosure [Text Block]	I. Income Taxes To determine our quarterly provision for income taxes, we use an estimated annual effective tax rate, which is based on expected annual income (or loss), statutory tax rates and tax planning opportunities available in the various jurisdictions to which we are subject. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rate from quarter to quarter. We recognize interest and penalties related to uncertain tax positions, if any, as an income tax expense. Our effective tax rate for the three March 31, 2024 three March 31, 2023, nine March 31, 2024, nine March 31, 2023 three nine March 31, 2024 2024 We record valuation allowances to reduce our deferred tax assets to an amount we believe is more likely than not not three nine March 31, 2024 no

Note J - Treasury Stock

Note J - Treasury Stock	9 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Equity [Text Block]	J. Treasury Stock At times we purchase our shares under a stock repurchase plan (“Repurchase Plan”) authorized by the Board of Directors. The current total authorized repurchase amount is $18.0 million and as of March 31, 2024 may, February 13, 2024, not Stock repurchases for the three nine March 31, 2024 Shares Average Cost Total Cost (in thousands) Shares purchased under Repurchase Plan — $ — $ — Shares acquired from employees for restricted stock vesting 36,444 5.95 217 Total 36,444 $ 217 Stock repurchases for the three March 31, 2023 Shares Average Cost Total Cost (in thousands) Shares purchased under Repurchase Plan 25,447 $ 9.23 $ 235 Shares acquired from employees for restricted stock vesting 23,587 8.86 209 Total 49,034 $ 444 Stock repurchases for the nine March 31, 2023 Shares Average Cost Total Cost (in thousands) Shares purchased under Repurchase Plan 140,812 $ 9.19 $ 1,294 Shares acquired from employees for restricted stock vesting 23,587 8.86 209 Total 164,399 $ 1,503 Stock repurchase costs include commissions and fees. Shares acquired from employees for restricted stock vesting may

Note K - Derivatives and Hedgin

Note K - Derivatives and Hedging	9 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Derivative Instruments and Hedging Activities Disclosure [Text Block]	K. Derivatives and Hedging We are exposed to gains and losses resulting from fluctuations in foreign currency exchange rates relating to forecasted product sales denominated in foreign currencies and to other transactions of NAIE, our foreign subsidiary. As part of our overall strategy to manage the level of exposure to the risk of fluctuations in foreign currency exchange rates, we may no As of March 31, 2024 September 2024. For foreign currency contracts designated as cash flow hedges, hedge effectiveness is measured using the spot rate. Changes in the spot-forward differential are excluded from the test of hedge effectiveness and are recorded currently in earnings as revenue. We measure effectiveness by comparing the cumulative change in the hedge contract with the cumulative change in the hedged item. No three nine March 31, 2024 March 31, 2023 We monitor the probability of forecasted transactions as part of the hedge effectiveness testing on a quarterly basis. During the three nine March 31, 2024 March 31, 2023 not As of March 31, 2024 March 31, 2024 12 For foreign currency contracts not three nine March 31, 2024 March 31, 2024 not We are exposed to interest rate fluctuations related to our $10.0 million Term Note with Wells Fargo, which carries a variable interest rate of 1.80% above the SOFR rolling 30 August 23, 2021, first three SOFR 2.4%.

Note L - Contingencies

Note L - Contingencies	9 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Legal Matters and Contingencies [Text Block]	L. Contingencies From time to time, we become involved in various investigations, claims and legal proceedings that arise in the ordinary course of our business. These matters may may not not Israel-Hamas War In October 2023, not may may

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2024
Insider Trading Arr Line Items
Material Terms of Trading Arrangement [Text Block]		5. OTHER INFORMATION None.
Rule 10b5-1 Arrangement Terminated [Flag]	false
Rule 10b5-1 Arrangement Adopted [Flag]	false
Non-Rule 10b5-1 Arrangement Terminated [Flag]	false
Non-Rule 10b5-1 Arrangement Adopted [Flag]	false

Significant Accounting Policies

Significant Accounting Policies (Policies)	9 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Adopted Accounting Pronouncements We did not three March 31, 2024. Recently Issued Accounting and Regulatory Pronouncements In October 2023, 2023 06, 2023 06 X not not June 30, 2027. not In November 2023, 2023 07, 280 2023 07 December 15, 2023, 2025. not In December 2023, 2023 09, 740 2023 09 December 15, 2024, first 2026. not In March 2024, No. 33 11275, July 1, 2027. April 2024, may may
Earnings Per Share, Policy [Policy Text Block]	Net (Loss) Income per Common Share We compute net (loss) income per common share using the weighted average number of common shares outstanding during the period, and diluted net income per common share using the additional dilutive effect of all dilutive securities. The dilutive impact of unvested restricted shares account for the additional weighted average shares of common stock outstanding for our diluted net income per common share computation. We calculated basic and diluted net (loss) income per common share as follows (in thousands, except per share data): Three Months Ended Nine Months Ended March 31, March 31, 2024 2023 2024 2023 Numerator Net (loss) income $ (1,578 ) $ (2,381 ) $ (5,343 ) $ 485 Denominator Basic weighted average common shares outstanding 5,868 5,816 5,856 5,867 Dilutive effect of restricted stock — — — 18 Diluted weighted average common shares outstanding 5,868 5,816 5,856 5,885 Basic net (loss) income per common share $ (0.27 ) $ (0.41 ) $ (0.91 ) $ 0.08 Diluted net (loss) income per common share $ (0.27 ) $ (0.41 ) $ (0.91 ) $ 0.08 We exclude the impact of restricted stock from the calculation of diluted net loss per common share in periods where we have a net loss or when their inclusion would be antidilutive. During the three March 31, 2024, nine March 31, 2024, three March 31, 2023, nine March 31, 2023
Revenue [Policy Text Block]	Revenue Recognition We record revenue based on a five 1 2 3 4 5 Revenue is measured as the net amount of consideration expected to be received in exchange for fulfilling one 30 Revenue is recognized at the point in time that each of our performance obligations is fulfilled, and control of the ordered products is transferred to the customer. This transfer occurs when the product is shipped, or in some cases, when the product is delivered to the customer. We recognize revenue in certain circumstances before delivery to the customer has occurred (commonly referred to as bill-and-hold transactions). Products sold under bill-and-hold arrangements are recorded as revenue when risk of ownership has been transferred to the customer, but the product has not We provide early payment discounts to certain customers. Based on historical payment trends, we expect that these customers will take advantage of these early payment discounts. The cost of these discounts is reported as a reduction to the transaction price. If the actual discounts differ from those estimated, the difference is also reported as a change in the transaction price. We require prepayment from certain customers. We record any payments received in advance of contract fulfillment as a contract liability and they are classified as customer deposits on the consolidated balance sheet. Contract liabilities and revenue recognized were as follows (in thousands): June 30, 2023 Additions Revenue Recognized Customer Refunds March 31, 2024 Contract Liabilities (Customer Deposits) $ 317 $ 1,406 $ (1,336 ) $ — $ 387 June 30, 2022 Additions Revenue Recognized Customer Refunds March 31, 2023 Contract Liabilities (Customer Deposits) $ 140 $ 326 $ (137 ) $ (3 ) $ 326 Except for product defects, no March 31, 2024 We currently own certain U.S. patents, and each patent’s corresponding foreign patent applications. All of these patents and patent rights relate to the ingredient known as beta-alanine marketed and sold under our CarnoSyn® and SR CarnoSyn® trade names. We recorded beta-alanine raw material sales and royalty and licensing income as a component of revenue in the amount of $2.7 million during the three March 31, 2024 nine March 31, 2024. three March 31, 2023 nine March 31, 2023. three March 31, 2024 nine March 31, 2024. three March 31, 2023 nine March 31, 2023.
Share-Based Payment Arrangement [Policy Text Block]	Stock-Based Compensation The Board of Directors approved our current omnibus equity incentive plan that became effective January 1, 2021 ( “2020 2020 December 4, 2020. 2020 may We did not three nine March 31, 2024 March 31, 2023 During the three March 31, 2024 nine March 31, 2024, three nine March 31, 2023, three nine March 31, 2024, three nine March 31, 2023, three March 31, 2024 nine March 31, 2024. three March 31, 2023, nine March 31, 2023.
Compensation Related Costs, Policy [Policy Text Block]	Deferred Compensation Plan Effective July 16, 2020, may The Incentive Plan authorizes the Human Resources Committee or the Board of Directors to grant to, and administer, unsecured and deferred cash Awards to Participants and to subject each Award to whatever conditions are determined appropriate by the Human Resources Committee or the Board of Directors. The terms of each Award, including the amount and any conditions that must be met to be entitled to payment of the Award are set forth in an Award Agreement between each Participant and NAI. The Incentive Plan provides the Board of Directors with the discretion to set aside assets to fund the Incentive Plan although that has not During the three nine March 31, 2024, three nine March 31, 2023, three one two three no No deferred cash awards were forfeited during the three nine March 31, 2024 March 31, 2023
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments Except for cash and cash equivalents, as of March 31, 2024 June 30, 2023 not 1. 2 third Fair value of derivative instruments classified as Level 2 March 31, 2024 June 30, 2023 Euro Forward Contract– Current Assets $ 335 $ 250 Swiss Franc Forward Contract – Current Assets — 140 Total Derivative Contracts – Current Assets 335 390 Interest Swap – Other noncurrent Assets 221 532 Euro Forward Contract– Other noncurrent Assets — 15 Total Derivative Contracts – Other noncurrent Assets 221 547 Euro Forward Contract– Current Liabilities — — Swiss Franc Forward Contract – Current Liabilities (345 ) — Total Derivative Contracts – Current Liabilities (345 ) — Fair Value Net Asset – all Derivative Contracts $ 211 $ 937 We also classify any outstanding line of credit and term loan balance as a Level 2 March 31, 2024 June 30, 2023 not 3. not 2023 three nine March 31, 2024

Note A - Basis of Presentatio_2

Note A - Basis of Presentation and Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Mar. 31, 2024
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended Nine Months Ended March 31, March 31, 2024 2023 2024 2023 Numerator Net (loss) income $ (1,578 ) $ (2,381 ) $ (5,343 ) $ 485 Denominator Basic weighted average common shares outstanding 5,868 5,816 5,856 5,867 Dilutive effect of restricted stock — — — 18 Diluted weighted average common shares outstanding 5,868 5,816 5,856 5,885 Basic net (loss) income per common share $ (0.27 ) $ (0.41 ) $ (0.91 ) $ 0.08 Diluted net (loss) income per common share $ (0.27 ) $ (0.41 ) $ (0.91 ) $ 0.08
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]	June 30, 2023 Additions Revenue Recognized Customer Refunds March 31, 2024 Contract Liabilities (Customer Deposits) $ 317 $ 1,406 $ (1,336 ) $ — $ 387 June 30, 2022 Additions Revenue Recognized Customer Refunds March 31, 2023 Contract Liabilities (Customer Deposits) $ 140 $ 326 $ (137 ) $ (3 ) $ 326
Fair Value, by Balance Sheet Grouping [Table Text Block]	March 31, 2024 June 30, 2023 Euro Forward Contract– Current Assets $ 335 $ 250 Swiss Franc Forward Contract – Current Assets — 140 Total Derivative Contracts – Current Assets 335 390 Interest Swap – Other noncurrent Assets 221 532 Euro Forward Contract– Other noncurrent Assets — 15 Total Derivative Contracts – Other noncurrent Assets 221 547 Euro Forward Contract– Current Liabilities — — Swiss Franc Forward Contract – Current Liabilities (345 ) — Total Derivative Contracts – Current Liabilities (345 ) — Fair Value Net Asset – all Derivative Contracts $ 211 $ 937

Note B - Inventories, Net (Tabl

Note B - Inventories, Net (Tables)	9 Months Ended
	Mar. 31, 2024
Notes Tables
Schedule of Inventory, Current [Table Text Block]	March 31, June 30, 2024 2023 Raw materials $ 15,219 $ 20,946 Work in progress 3,261 4,504 Finished goods 3,273 4,928 Reserve (682 ) (684 ) $ 21,071 $ 29,694

Note C - Property and Equipme_2

Note C - Property and Equipment (Tables)	9 Months Ended
	Mar. 31, 2024
Notes Tables
Property, Plant and Equipment [Table Text Block]	Depreciable Life March 31, June 30, In Years 2024 2023 Land NA $ 8,941 $ 8,940 Building and building improvements 7 – 39 25,251 24,712 Machinery and equipment 3 – 12 42,318 41,460 Office equipment and furniture 3 – 5 6,616 6,522 Vehicles 3 227 227 Leasehold improvements 1 – 15 23,133 22,641 Total property and equipment 106,486 104,502 Less: accumulated depreciation and amortization (54,102 ) (50,661 ) Property and equipment, net $ 52,384 $ 53,841

Note D - Other Comprehensive _2

Note D - Other Comprehensive (Loss) Income (Tables)	9 Months Ended
	Mar. 31, 2024
Notes Tables
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	Three Months Ended March 31, 2024 Defined Unrealized (Losses) Unrealized Gains Benefit Gains on (Losses) on Pension Cash Flow Swap Plan Hedges Derivative Total Beginning Balance $ (390 ) $ (104 ) $ 252 $ (242 ) OCI/OCL before reclassifications — 285 (96 ) 189 Amounts reclassified from OCI to Sales — (35 ) — (35 ) Tax effect of OCI activity 5 (52 ) 17 (30 ) Net current period OCI/OCL 5 198 (79 ) 124 Ending Balance $ (385 ) $ 94 $ 173 $ (118 ) Nine Months Ended March 31, 2024 Defined Unrealized Gains Unrealized Gains Benefit (Losses) on (Losses) on Pension Cash Flow Swap Plan Hedges Derivative Total Beginning Balance $ (380 ) $ (110 ) $ 407 $ (83 ) OCI/OCL before reclassifications — 286 (311 ) (25 ) Amounts reclassified from OCI to Sales — 54 — 54 Tax effect of OCI activity (5 ) (136 ) 77 (64 ) Net current period OCI/OCL (5 ) 204 (234 ) (35 ) Ending Balance $ (385 ) $ 94 $ 173 $ (118 ) Three Months Ended March 31, 2023 Defined Unrealized Gains Unrealized Gains Benefit (Losses) on (Losses) on Pension Cash Flow Swap Plan Hedges Derivative Total Beginning Balance $ (444 ) $ 391 $ 488 $ 435 OCI/OCL before reclassifications — 713 (90 ) 623 Amounts reclassified from OCI to Sales — (1,181 ) — (1,181 ) Tax effect of OCI activity — 122 79 201 Net current period OCI/OCL — (346 ) (11 ) (357 ) Ending Balance $ (444 ) $ 45 $ 477 $ 78 Nine Months Ended March 31, 2023 Defined Unrealized Gains Unrealized Gains Benefit (Losses) on (Losses) on Pension Cash Flow Swap Plan Hedges Derivative Total Beginning Balance $ (444 ) $ 1,795 $ 348 $ 1,699 OCI/OCL before reclassifications — 1,328 88 1,416 Amounts reclassified from OCI to Sales — (3,604 ) 41 (3,563 ) Tax effect of OCI activity — 526 — 526 Net current period OCI/OCL — (1,750 ) 129 (1,621 ) Ending Balance $ (444 ) $ 45 $ 477 $ 78

Note E - Leases (Tables)

Note E - Leases (Tables)	9 Months Ended
	Mar. 31, 2024
Notes Tables
Lease, Cost [Table Text Block]	Supplemental Cash Flow Information Nine Months Ended Nine Months Ended March 31, 2024 March 31, 2023 Cash paid for amounts included in the measurement of operating lease liabilities $ 2,523 $ 2,433 Increase in operating lease liabilities and right-of-use assets due to lease remeasurement $ 25,589 $ —

Note G - Economic Dependency (T

Note G - Economic Dependency (Tables)	9 Months Ended
	Mar. 31, 2024
Supplier Concentration Risk [Member]
Notes Tables
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	Three Months Ended Nine Months Ended March 31, March 31, 2024 2023 2024 2023 Supplier 1 $ 4,149 3,916 $ 10,018 11,394 $ 4,149 $ 3,916 $ 10,018 $ 11,394
Customer Concentration Risk [Member]
Notes Tables
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	Three Months Ended Nine Months Ended March 31, March 31, 2024 2023 2024 2023 Customer 1 $ 11,251 $ 15,962 $ 35,215 $ 46,948 Customer 2 (a) 9,558 13,604 38,823 Customer 3 2,640 (a) (a) (a) $ 13,891 $ 25,520 $ 48,819 $ 85,771

Note H - Segment Information (T

Note H - Segment Information (Tables)	9 Months Ended
	Mar. 31, 2024
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Three Months Ended Nine Months Ended March 31, March 31, 2024 2023 2024 2023 Net Sales Private label contract manufacturing $ 22,479 $ 30,354 $ 77,718 $ 112,969 Patent and trademark licensing 2,657 2,345 6,589 5,152 Total Net Sales $ 25,136 $ 32,699 $ 84,307 $ 118,121 Three Months Ended Nine Months Ended March 31, March 31, 2024 2023 2024 2023 (Loss) Income from Operations Private label contract manufacturing $ (1,007 ) $ (1,243 ) $ (2,367 ) $ 6,264 Patent and trademark licensing 1,201 790 $ 2,592 1,485 Income (Loss) from operations of reportable segments 194 (453 ) $ 225 7,749 Corporate expenses not allocated to segments (2,146 ) (2,035 ) $ (6,234 ) (6,210 ) Total (Loss) Income from Operations $ (1,952 ) $ (2,488 ) $ (6,009 ) $ 1,539
Reconciliation of Assets from Segment to Consolidated [Table Text Block]	March 31, June 30, 2024 2023 Total Assets Private-label contract manufacturing $ 119,245 $ 102,495 Patent and trademark licensing 33,966 31,657 $ 153,211 $ 134,152
Revenue from External Customers by Geographic Areas [Table Text Block]	Three Months Ended Nine Months Ended March 31, March 31, 2024 2023 2024 2023 United States $ 15,457 $ 24,254 $ 56,990 $ 82,995 Markets outside of the United States 9,679 8,445 27,317 35,126 Total $ 25,136 $ 32,699 $ 84,307 $ 118,121
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]	March 31, 2024 June 30, 2023 United States $ 78,238 $ 53,536 Europe 18,178 20,674 Total Long-Lived Assets $ 96,416 $ 74,210
Assets by Geographic Areas [Table Text Block]	March 31, 2024 June 30, 2023 United States $ 109,465 $ 89,167 Europe 43,746 44,985 Total Assets $ 153,211 $ 134,152
Capital Expenditures by Geographic Areas [Table Text Block]	Nine Months Ended March 31, 2024 2023 United States $ 1,801 $ 12,983 Europe 182 256 Total Capital Expenditures $ 1,983 $ 13,239

Note J - Treasury Stock (Tables

Note J - Treasury Stock (Tables)	9 Months Ended
	Mar. 31, 2024
Notes Tables
Class of Treasury Stock [Table Text Block]	Shares Average Cost Total Cost (in thousands) Shares purchased under Repurchase Plan — $ — $ — Shares acquired from employees for restricted stock vesting 36,444 5.95 217 Total 36,444 $ 217 Shares Average Cost Total Cost (in thousands) Shares purchased under Repurchase Plan 25,447 $ 9.23 $ 235 Shares acquired from employees for restricted stock vesting 23,587 8.86 209 Total 49,034 $ 444 Shares Average Cost Total Cost (in thousands) Shares purchased under Repurchase Plan 140,812 $ 9.19 $ 1,294 Shares acquired from employees for restricted stock vesting 23,587 8.86 209 Total 164,399 $ 1,503

Note A - Basis of Presentatio_3

Note A - Basis of Presentation and Summary of Significant Accounting Policies (Details Textual) - USD ($)	3 Months Ended		8 Months Ended	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Contract with Customer, Refund Liability	$ 0			$ 0
Sales, Royalty and Licensing Revenue	2,700,000	$ 2,300,000		6,600,000	$ 5,200,000
Royalty Expense	$ 96,000	$ 107,000		$ 278,000	$ 213,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)	0	0		0	0
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)	151,500	118,000		166,500	118,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period (in shares)	3,000	5,999		3,000	5,999
Share-Based Payment Arrangement, Expense	$ 300,000	$ 300,000	$ 700,000	$ 900,000
Deferred Compensation Arrangement with Individual, Cash Award Granted, Amount	900,000			900,000		$ 600,000
Deferred Compensation Arrangement with Individual, Cash Award Forfeited, Amount	$ 0	$ 0		$ 0	$ 0
Restricted Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	173,230	227,082		215,180	151,585

Note A - Basis of Presentatio_4

Note A - Basis of Presentation and Summary of Significant Accounting Policies - Calculation of Basic and Diluted Net Income Per Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2023
Numerator
Net (loss) income	$ (1,578)	$ (2,381)	$ (5,343)	$ (5,343)	$ 485	$ 485
Denominator
Basic weighted average common shares outstanding (in shares)	5,867,528	5,816,058	5,856,000	5,855,930	5,867,000	5,867,400
Dilutive effect of restricted stock (in shares)	0	0	0		18,000
Diluted weighted average common shares outstanding (in shares)	5,867,528	5,816,058	5,856,000	5,855,930	5,885,000	5,885,116
Basic net (loss) income per common share (in dollars per share)	$ (0.27)	$ (0.41)	$ (0.91)	$ (0.91)	$ 0.08	$ 0.08
Diluted net (loss) income per common share (in dollars per share)	$ (0.27)	$ (0.41)	$ (0.91)	$ (0.91)	$ 0.08	$ 0.08

Note A - Basis of Presentatio_5

Note A - Basis of Presentation and Summary of Significant Accounting Policies - Contract Liabilities and Revenue Recognized (Details) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Contract Liabilities (Customer Deposits), balance	$ 317	$ 140
Contract Liabilities (Customer Deposits), addition	1,406	326
Contract Liabilities (Customer Deposits), revenue recognized	(1,336)	137
Contract Liabilities (Customer Deposits)	0	(3)
Contract Liabilities (Customer Deposits), balance	387	326
Contract Liabilities (Customer Deposits), revenue recognized	$ 1,336	$ (137)

Note A - Basis of Presentatio_6

Note A - Basis of Presentation and Summary of Significant Accounting Policies - Fair Value of Derivative Instruments Classified As Level 2 Assets and Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Jun. 30, 2023
Derivative assets, current asset	$ 335	$ 390
Derivative assets, current liability	(345)	0
Fair Value, Inputs, Level 2 [Member]
Derivative assets, current asset	335	390
Derivative assets, noncurrent asset	221	547
Derivative assets, current liability	(345)	0
Fair Value Net Asset – all Derivative Contracts	211	937
Fair Value, Inputs, Level 2 [Member] | Euro Forward Contract [Member]
Derivative assets, current asset	335	250
Derivative assets, noncurrent asset	0	15
Derivative assets, current liability	0	0
Fair Value, Inputs, Level 2 [Member] | Swiss Franc Forward Contract [Member]
Derivative assets, current asset	0	140
Derivative assets, current liability	(345)	0
Fair Value, Inputs, Level 2 [Member] | Interest Rate Swap [Member]
Derivative assets, noncurrent asset	$ 221	$ 532

Note B - Inventories, Net - Sum

Note B - Inventories, Net - Summary of Inventories (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Jun. 30, 2023
Raw materials	$ 15,219	$ 20,946
Work in progress	3,261	4,504
Finished goods	3,273	4,928
Reserve	(682)	(684)
Inventory, Net	$ 21,071	$ 29,694

Note C - Property and Equipme_3

Note C - Property and Equipment (Details Textual) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Depreciation	$ 1.1	$ 1	$ 3.4	$ 3.1

Note C - Property and Equipme_4

Note C - Property and Equipment - Summary of Property and Equipment (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Jun. 30, 2023
Property and equipment, gross	$ 106,486	$ 104,502
Less: accumulated depreciation and amortization	(54,102)	(50,661)
Property and equipment, net	52,384	53,841
Land [Member]
Property and equipment, gross	8,941	8,940
Building and Building Improvements [Member]
Property and equipment, gross	$ 25,251	24,712
Building and Building Improvements [Member] | Minimum [Member]
Depreciable Life In Years (Year)	7 years
Building and Building Improvements [Member] | Maximum [Member]
Depreciable Life In Years (Year)	39 years
Machinery and Equipment [Member]
Property and equipment, gross	$ 42,318	41,460
Machinery and Equipment [Member] | Minimum [Member]
Depreciable Life In Years (Year)	3 years
Machinery and Equipment [Member] | Maximum [Member]
Depreciable Life In Years (Year)	12 years
Office Equipment [Member]
Property and equipment, gross	$ 6,616	6,522
Office Equipment [Member] | Minimum [Member]
Depreciable Life In Years (Year)	3 years
Office Equipment [Member] | Maximum [Member]
Depreciable Life In Years (Year)	5 years
Vehicles [Member]
Property and equipment, gross	$ 227	227
Depreciable Life In Years (Year)	3 years
Leasehold Improvements [Member]
Property and equipment, gross	$ 23,133	$ 22,641
Leasehold Improvements [Member] | Minimum [Member]
Depreciable Life In Years (Year)	1 year
Leasehold Improvements [Member] | Maximum [Member]
Depreciable Life In Years (Year)	15 years

Note D - Other Comprehensive _3

Note D - Other Comprehensive (Loss) Income - Other Comprehensive (Loss) Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Balance	$ 85,455	$ 89,530	$ 88,772	$ 88,520
Balance	84,099	86,606	84,099	86,606
Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]
Balance	(390)	(444)	(380)	(444)
OCI/OCL before reclassifications	0	0	0	0
Amounts reclassified from OCI to Sales	0	0	0	0
Tax effect of OCI activity	5	0	(5)	0
Net current period OCI/OCL	5	0	(5)	0
Balance	(385)	(444)	(385)	(444)
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]
Balance	(104)	391	(110)	1,795
OCI/OCL before reclassifications	285	713	286	1,328
Amounts reclassified from OCI to Sales	(35)	(1,181)	54	(3,604)
Tax effect of OCI activity	(52)	122	(136)	526
Net current period OCI/OCL	198	(346)	204	(1,750)
Balance	94	45	94	45
Accumulated Gain (Loss), Net, Swap Derivative, Parent [Member]
Balance	252	488	407	348
OCI/OCL before reclassifications	(96)	(90)	(311)	88
Amounts reclassified from OCI to Sales	0	0	0	41
Tax effect of OCI activity	17	79	77	0
Net current period OCI/OCL	(79)	(11)	(234)	129
Balance	173	477	173	477
AOCI Attributable to Parent [Member]
Balance	(242)	435	(83)	1,699
OCI/OCL before reclassifications	189	623	(25)	1,416
Amounts reclassified from OCI to Sales	(35)	(1,181)	54	(3,563)
Tax effect of OCI activity	(30)	201	(64)	526
Net current period OCI/OCL	124	(357)	(35)	(1,621)
Balance	$ (118)	$ 78	$ (118)	$ 78

Note E - Leases (Details Textua

Note E - Leases (Details Textual)	Jul. 18, 2023 USD ($) a	Mar. 31, 2024 USD ($)	Jan. 26, 2024 USD ($)	Jun. 30, 2023 USD ($)
Operating Lease, Right-of-Use Asset		$ 44,032,000		$ 20,369,000
Operating Lease, Weighted Average Remaining Lease Term (Year)		9 years 8 months 12 days		5 years 3 months 18 days
Operating Lease, Weighted Average Discount Rate, Percent		5.92%		4.12%
Extension on Manufacturing Facilities Lease [Member]
Operating Lease, Right-of-Use Asset	$ 25,900,000
Operating Lease, Liability	$ 25,900,000
Early Termination of Manno, Switzerland Apartment Lease [Member]
Operating Lease, Right-of-Use Asset			$ 300,000
Operating Lease, Liability			$ 300,000
California 1 [Member]
Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract (Year)	10 years 4 months 24 days
Area of Real Estate Property (Acre) | a	162,000
Operating Lease, Base Rent Per Square Foot	$ 1.5
Tenant Improvements	2,300,000
California 1 [Member] | Reimbursements For Tenant Improvements [Member]
Tenant Improvements	$ 1,100,000
Manno, Switzerland [Member]
Operating Lease, Weighted Average Remaining Lease Term (Year)			9 years 7 months 28 days

Note E - Leases - Lease Cash Fl

Note E - Leases - Lease Cash Flow Information (Details) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash paid for amounts included in the measurement of operating lease liabilities	$ 2,523	$ 2,433
Increase in operating lease liabilities and right-of-use assets due to lease remeasurement	$ 25,589	$ 0

Note F - Debt (Details Textual)

Note F - Debt (Details Textual)				9 Months Ended
	Feb. 13, 2024 USD ($)	Aug. 20, 2021 USD ($)	Aug. 18, 2021 USD ($)	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	Jun. 30, 2022 USD ($)	Aug. 23, 2021	Jun. 30, 2021 USD ($)	May 24, 2021 USD ($)
Payments to Acquire Property, Plant, and Equipment, Total				$ 1,983,000	$ 13,239,000
Interest Rate Swap [Member]
Derivative, Fixed Interest Rate			2.40%				2.40%
Manufacturing Facility and Warehouse [Member] | Carlsbad, California [Member]
Payments to Acquire Property, Plant, and Equipment, Total		$ 17,500,000
Wells Fargo Bank, N.A. [Member] | Credit Agreement [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 12,500,000								$ 20,000,000
Debt Instrument Covenant Capital Expenditures Limitation, Amount, Next Twelve Years						$ 15,000,000		$ 10,000,000
Debt Instrument Covenant Minimum, Net Income Required	$ 1
Debt Instrument Covenant, Fixed Charge Coverage Ratio	1.25
Debt Instrument Covenant Capital Expenditures Limitation, Amount, After Twelve Years	$ 6,500,000
Line of Credit, Availability Reserve Percentage	10%
Long-term Debt, Percentage Bearing Fluctuating Interest, Threshold Amount	$ 100,000
Line of Credit Facility, Unused Commitment Fee	0.25%
Debt Instrument Basis Spread on Elected Fixed Rate Borrowing	1%
Line of Credit Facility, Remaining Borrowing Capacity				6,400,000
Wells Fargo Bank, N.A. [Member] | Credit Agreement [Member] | Maximum [Member]
Ratio of Indebtedness to Net Capital	1.5
Wells Fargo Bank, N.A. [Member] | Credit Agreement [Member] | Secured Overnight Financing Rate (SOFR) [Member]
Debt Instrument, Basis Spread on Variable Rate	2.25%		1.29%
Wells Fargo Bank, N.A. [Member] | Credit Agreement [Member] | Term Loan [Member]
Debt Instrument, Face Amount			$ 10,000,000
Debt Instrument, Basis Spread on Variable Rate			1.80%
Debt Instrument, Term (Year)			7 years
Long-Term Debt				$ 9,300,000
Wells Fargo Bank, N.A. [Member] | Credit Agreement [Member] | Term Loan [Member] | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]
Debt Instrument, Basis Spread on Variable Rate			1.80%

Note G - Economic Dependency (D

Note G - Economic Dependency (Details Textual) - USD ($) $ in Millions	Mar. 31, 2024	Jun. 30, 2023
Three Customers [Member]
Accounts Receivable, after Allowance for Credit Loss	$ 7.6	$ 5.2

Note G - Economic Dependency -

Note G - Economic Dependency - Substantial Net Sales to Certain Customers (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2023
Net sales	$ 25,136	$ 32,699	$ 84,307	$ 84,307	$ 118,121	$ 118,121
Customer Concentration Risk [Member] | Revenue Benchmark [Member]
Net sales	13,891	25,520	48,819		85,771
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer 1 [Member]
Net sales	11,251	15,962	35,215		46,948
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer 2 [Member]
Net sales		$ 9,558	$ 13,604		$ 38,823
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer 3 [Member]
Net sales	$ 2,640

Note G - Economic Dependency _2

Note G - Economic Dependency - Substantial Net Purchase From Certain Suppliers (Details) - Supplier Concentration Risk [Member] - Raw Material Purchases [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Raw Material Purchases by Supplier	$ 4,149	$ 3,916	$ 10,018	$ 11,394
Supplier 1 [Member]
Raw Material Purchases by Supplier	$ 4,149	$ 3,916	$ 10,018	$ 11,394

Note H - Segment Information (D

Note H - Segment Information (Details Textual)	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Number of Reportable Segments	2
Products Manufactured by NAIE [Member] | Product Concentration Risk [Member] | Revenue Benchmark [Member] | Non-US [Member]
Concentration Risk, Percentage	68%	81%	76%	76%

Note H - Segment Information -

Note H - Segment Information - Operating Results by Business Segment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2023
Net Sales	$ 25,136	$ 32,699	$ 84,307	$ 84,307	$ 118,121	$ 118,121
Income from operations	(1,952)	(2,488)	(6,009)	$ (6,009)	1,539	$ 1,539
Operating Segments [Member]
Income from operations	194	(453)	225		7,749
Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]
Income from operations	(2,146)	(2,035)	(6,234)		(6,210)
Private Label Contract Manufacturing [Member]
Net Sales	22,479	30,354	77,718		112,969
Private Label Contract Manufacturing [Member] | Operating Segments [Member]
Income from operations	(1,007)	(1,243)	(2,367)		6,264
Patent and Trademark Licensing [Member]
Net Sales	2,657	2,345	6,589		5,152
Patent and Trademark Licensing [Member] | Operating Segments [Member]
Income from operations	$ 1,201	$ 790	$ 2,592		$ 1,485

Note H - Segment Information _2

Note H - Segment Information - Assets by Business Segment (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Jun. 30, 2023
Total Assets	$ 153,211	$ 134,152
Private Label Contract Manufacturing [Member]
Total Assets	119,245	102,495
Patent and Trademark Licensing [Member]
Total Assets	$ 33,966	$ 31,657

Note H - Segment Information _3

Note H - Segment Information - Net Sales by Geographic Region (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2023
Net sales	$ 25,136	$ 32,699	$ 84,307	$ 84,307	$ 118,121	$ 118,121
UNITED STATES
Net sales	15,457	24,254	56,990		82,995
Non-US [Member]
Net sales	$ 9,679	$ 8,445	$ 27,317		$ 35,126

Note H - Segment Information _4

Note H - Segment Information - Long-lived Assets by Geographical Region (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Jun. 30, 2023
Long-Lived Assets	$ 96,416	$ 74,210
UNITED STATES
Long-Lived Assets	78,238	53,536
Europe [Member]
Long-Lived Assets	$ 18,178	$ 20,674

Note H - Segment Information _5

Note H - Segment Information - Total Assets by Geographical Region (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Jun. 30, 2023
Total Assets	$ 153,211	$ 134,152
UNITED STATES
Total Assets	109,465	89,167
Europe [Member]
Total Assets	$ 43,746	$ 44,985

Note H - Segment Information _6

Note H - Segment Information - Capital Expenditures by Geographical Region (Details) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Capital Expenditures	$ 1,983	$ 13,239
UNITED STATES
Capital Expenditures	1,801	12,983
Europe [Member]
Capital Expenditures	$ 182	$ 256

Note I - Income Taxes (Details

Note I - Income Taxes (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Effective Income Tax Rate Reconciliation, Percent	19.80%	14.60%	20.10%	40.60%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21%		21%
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$ 0		$ 0

Note J - Treasury Stock (Detail

Note J - Treasury Stock (Details Textual)	Mar. 31, 2024 USD ($)
Stock Repurchase Program, Authorized Amount	$ 18,000,000
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$ 716,000

Note J - Treasury Stock - Treas

Note J - Treasury Stock - Treasury Stock Repurchases (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Treasury Stock Acquired, Shares (in shares)	36,444	49,034		164,399
Treasury Stock Acquired, Total Cost	$ 217	$ 444	$ 217	$ 1,503
Stock Repurchase Plan [Member]
Treasury Stock Acquired, Shares (in shares)	0	25,447		140,812
Treasury Stock Acquired, Average Cost (in dollars per share)	$ 0	$ 9.23		$ 9.19
Treasury Stock Acquired, Total Cost	$ 0	$ 235		$ 1,294
Stock Repurchased from Employee for Restricted Stock Vesting [Member]
Treasury Stock Acquired, Shares (in shares)	36,444	23,587		23,587
Treasury Stock Acquired, Average Cost (in dollars per share)	$ 5.95	$ 8.86		$ 8.86
Treasury Stock Acquired, Total Cost	$ 217	$ 209		$ 209

Note K - Derivatives and Hedg_2

Note K - Derivatives and Hedging (Details Textual) € in Millions, SFr in Millions	Aug. 18, 2021 USD ($)	Mar. 31, 2024 USD ($)	Mar. 31, 2024 EUR (€)	Mar. 31, 2024 CHF (SFr)	Aug. 23, 2021
Accumulated Other Comprehensive Income (Loss) Cumulative Cash Flow Hedges, Gain (Loss)		$ 100,000
Deferred Tax Assets, Derivative Instruments		26,000
Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]	Secured Overnight Financing Rate (SOFR) [Member]
Wells Fargo Bank, N.A. [Member] | Credit Agreement [Member] | Term Loan [Member]
Debt Instrument, Face Amount	$ 10,000,000
Debt Instrument, Basis Spread on Variable Rate	1.80%
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member]
Derivative, Notional Amount		12,600,000		SFr 11
Interest Rate Swap [Member]
Derivative, Fixed Interest Rate	2.40%				2.40%
Cash Flow Hedging [Member] | Foreign Exchange Contract [Member]
Derivative, Notional Amount		$ 13,600,000	€ 12.2